What's happening
This bill creates an interstate compact to incentivize disease cures by awarding prizes to those who develop successful treatments.
Why it matters
Shifts Incentives for Medical Innovation. By tying the prize amount to the actual public health savings from a cure, the compact directly aligns financial rewards with the societal value of eradicating diseases, potentially redirecting research priorities toward curative rather than merely profitable treatments.
Enables Collective State Action. The compact structure allows states (and potentially the federal government and even other countries as non-voting members) to pool resources and coordinate efforts, amplifying the incentive beyond what any single state might offer and making large-scale cures more financially attractive to innovators.
Ensures Public Access and Affordability. Prize winners must transfer intellectual property to the compact, which then makes the cure widely available and sets the price to cover only manufacturing and distribution costs (plus royalties for non-member states), mitigating monopolistic pricing and improving public access to breakthrough treatments.
Prioritizes Ethical Standards and Accountability. The commission must create and update a common set of ethical standards—reflecting the strictest laws of all U.S. states—for any prize-claiming research, and is subject to transparency, dispute resolution, and regular audits, aiming to prevent abuses and ensure responsible, public-interest-driven operation.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Drug developers and medical researchers
The bill would offer prizes for qualifying disease cures, generally requiring winners to transfer patents and related intellectual property to the interstate commission.
Patients with diseases targeted for prizes
The commission would arrange broad access to accepted cures and cap their selling prices in participating states at manufacturing, distribution, licensing and necessary governmental costs.
New York budget officials and legislators
Participating states would owe annual membership dues and fund their prize obligations through payments based on actual annual public health savings from accepted cures.
Drug manufacturers serving nonparticipating states and foreign countries
The commission could impose royalties on manufacturers, producers and providers of prize-winning cures in those markets.
Headline styles
Reward Cures for Diseases
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Reward Cures for Diseases
In Assembly Committee · Codes · Sponsor Ron Kim
Full text
12 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2868
2023-2024 Regular Sessions
IN SENATE
January 25, 2023
Introduced by Sens. RIVERA, SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to adopting the solemn covenant of the states to award prizes for curing diseases interstate compact
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new article 49-A to read as follows:
ARTICLE 49-A
SOLEMN COVENANT OF THE STATES TO AWARD PRIZES FOR CURING DISEASES
Section 4999. Definitions.
4999-a. Establishment of the commission; membership.
4999-b. Powers of the commission.
4999-c. Meetings and voting.
4999-d. Bylaws.
4999-e. Rules.
4999-f. Committees.
4999-g. Finance.
4999-h. Records.
4999-i. Compliance.
4999-h. Records.
4999-j. Venue.
4999-k. Qualified immunity, defense, and indemnification.
4999-l. Compacting states, effective date, and amendment.
4999-m. Withdrawal, default, and expulsion.
4999-n. Severability and construction.
4999-o. Binding effect of compact and other laws.
§ 4999. Definitions. For purposes of this article:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01821-01-3
1. "Compacting state" means either of the following:
a. Any state that has enacted the compact and which has not withdrawn or been suspended pursuant section forty-nine hundred ninety-nine-m of this article;
b. The federal government in accordance with the commission's bylaws.
2. "Compact" means the solemn covenant of the states to award prizes for curing diseases enacted in this article.
3. "Non-compacting state" means any state or the federal government, if it is not at the time a compacting state.
4. "Public health expenses" means the amount of all costs paid by taxpayers in a specified geographic area relating to a particular disease.
5. "State" means any state, district, or territory of the United States of America.
§ 4999-a. Establishment of the commission; membership. 1. Upon the enactment of the compact by six states, the compacting states shall establish the Solemn Covenant of States Commission.
2. The commission is a body corporate and politic and an instrumentality of each of the compacting states and is solely responsible for its liabilities, except as otherwise specifically provided in the compact.
3. Each compacting state shall be represented by one member as selected by the compacting state. Each compacting state shall determine its member's qualifications and period of service and shall be responsible for any action to remove or suspend its member or to fill the member's position if it becomes vacant. Nothing in the compact shall be construed to affect a compacting state's authority regarding the qualification, selection, or service of its own member.
§ 4999-b. Powers of the commission. 1. To adopt bylaws and rules pursuant to sections forty-nine hundred ninety-nine-d and forty-nine hundred ninety-nine-c of this article, which shall have the force and effect of law and shall be binding in the compacting states to the extent and in the manner provided in the compact;
2. To receive and review in an expeditious manner treatments and therapeutic protocols for the cure of disease submitted to the commission and to award prizes for submissions that meet the commission's standards for a successful cure treatment or therapeutic protocol;
3. To make widely available a cure treatment or therapeutic protocol upon a prize winner claiming a prize and transferring any intellectual property necessary for the manufacture and distribution of the cure in accordance with subdivision three of section forty-nine hundred ninetynine-e of this article, including by arranging or contracting for the manufacturing, production, or provision of any drug, serum, or other substance, device, or process, provided that the commission does not market the cure or conduct any other activity regarding the cure not specifically authorized in the compact;
4. To establish a selling price for the cure, which shall be not more than the expenses for the cure's manufacturing, distribution, licensing, and any other necessary governmental requirements for compacting states, or those expenses plus any royalty fees, for noncompacting states; the price shall not include the expenses of any other activities;
5. In non-compacting states and foreign countries, to establish and collect royalty fees imposed on manufacturers, producers, and providers of any drug, serum, or other substance, device, or process used for a cure treatment or therapeutic protocol, for which a prize is awarded; royalty fees may be added to the sales price of the cure pursuant to subdivision four of this section; provided that the royalty fees shall cumulatively be not more than the estimated five-year savings in public health expenses for that state or country, as calculated by actuaries employed or contracted by the commission;
6. To do the following regarding the collected royalty fees:
a. Pay or reimburse expenses related to the payment of a prize, which shall include employing or contracting actuaries to calculate annual taxpayer savings amounts in compacting states in accordance with subdivision three of section forty-nine hundred ninety-nine-e of this article, and payment of interest and other expenses related to a loan obtained in accordance with subdivision three of section forty-nine hundred ninety-nine-e of this article;
b. Annually disburse any amounts remaining after making payments or reimbursements under paragraph a of this subdivision as refunds to compacting states based on the per cent of the state's prize obligation in relation to the total obligation amount of all compacting states;
7. To bring and prosecute legal proceedings or actions in its name as the commission;
8. To issue subpoenas requiring the attendance and testimony of witnesses and the production of evidence;
9. To establish and maintain offices;
10. To borrow, accept, or contract for personnel services, including personnel services from employees of a compacting state;
11. To hire employees, professionals, or specialists, and elect or appoint officers, and to fix their compensation, define their duties and give them appropriate authority to carry out the purposes of the compact, and determine their qualifications; and to establish the commission's personnel policies and programs relating to, among other things, conflicts of interest, rates of compensation, and qualifications of personnel;
12. To accept any and all appropriate donations and grants of money, equipment, supplies, materials, and services, and to receive, utilize, and dispose of the same; provided that at all times the commission shall strive to avoid any appearance of impropriety;
13. To lease, purchase, or accept appropriate gifts or donations of, or otherwise to own, hold, improve, or use, any property, real, personal, or mixed; provided, that at all times the commission shall strive to avoid any appearance of impropriety;
14. To sell, convey, mortgage, pledge, lease, exchange, abandon, or otherwise dispose of any property, real, personal, or mixed;
15. To monitor compacting states for compliance with the commission's bylaws and rules;
16. To enforce compliance by compacting states with the commission's bylaws and rules;
17. To provide for dispute resolution among compacting states or between the commission and those who submit treatments and therapeutic protocols for the cure of disease for consideration;
18. To establish a budget and make expenditures;
19. To borrow money;
20. To appoint committees, including management, legislative, and advisory committees comprised of members, state legislators or their representatives, medical professionals, and such other interested persons as may be designated by the commission;
21. To establish annual membership dues for compacting states, which shall be used for daily expenses of the commission and not for interest or prize payments;
22. To adopt and use a corporate seal;
23. To perform such other functions as may be necessary or appropriate to achieve the purposes of this article.
§ 4999-c. Meetings and voting. 1. The commission shall meet and take such actions as are consistent with the compact, bylaws, and rules.
2. A majority of the members of the commission shall constitute a quorum necessary in order to conduct business or take actions at meetings of the commission.
3. Each member of the commission shall have the right and power to cast one vote regarding matters determined or actions to be taken by the commission. Each member shall have the right and power to participate in the business and affairs of the commission.
4. A member shall vote in person or by such other means as provided in the commission's bylaws. The commission's bylaws may provide for members' participation in meetings by telephone or other means of communication.
5. The commission shall meet at least once during each calendar year. Additional meetings shall be held as set forth in the commission's bylaws.
6. No decision of the commission with respect to the approval of an award for a treatment or therapeutic process for the cure of a disease shall be effective unless two-thirds of all the members of the commission vote in favor thereof.
7. Guidelines and voting requirements for all other decisions of the commission shall be established in the commission's bylaws.
§ 4999-d. Bylaws. The commission shall, by a majority vote of all the members of the commission, prescribe bylaws to govern its conduct as may be necessary or appropriate to carry out the purposes, and exercise the powers, of the compact, including, but not limited to:
1. establishing the fiscal year of the commission;
2. providing reasonable procedures for appointing and electing members, as well as holding meetings, of the management committee;
3. providing reasonable standards and procedures:
a. for the establishment and meetings of other committees;
b. governing any general or specific delegation of any authority or function of the commission; and
c. voting guidelines and procedures for commission decisions.
4. providing reasonable procedures for calling and conducting meetings of the commission that shall consist of requiring a quorum to be present, ensuring reasonable advance notice of each such meeting and providing for the right of citizens to attend each such meeting with enumerated exceptions designed to protect the public's interest and the privacy of individuals.
5. providing a list of matters about which the commission may go into executive session and requiring a majority of all members of the commission vote to enter into such session. As soon as practicable, the commission shall make public:
a. a copy of the vote to go into executive session, revealing the vote of each member with no proxy votes allowed; and
b. the matter requiring executive session, without identifying the actual issues or individuals involved.
6. establishing the titles, duties, authority, and reasonable procedures for the election of the officers of the commission;
7. providing reasonable standards and procedures for the establishment of the personnel policies and programs of the commission. Notwithstanding any civil service or other similar laws of any compacting state, the commission's bylaws shall exclusively govern the personnel policies and programs of the commission;
8. allowing a mechanism for:
a. the federal government to join as a compacting state; and
b. foreign countries or subdivisions of those countries to join as liaison members by adopting the compact; provided that adopting countries or subdivisions shall not have voting power or the power to bind the commission in any way.
9. adopting a code of ethics to address permissible and prohibited activities of members and employees;
10. providing for the maintenance of the commission's books and records;
11. governing the acceptance of and accounting for donations, annual member dues, and other sources of funding and establishing the proportion of these funds to be allocated to prize amounts for treatments and therapeutic protocols that cure disease;
12. governing any fundraising efforts in which the commission wishes to engage; and
13. providing a mechanism for winding up the operations of the commission and the equitable disposition of any surplus funds that may exist after the termination of the compact after the payment and reserving of all its debts and obligations.
§ 4999-e. Rules. 1. The commission shall adopt rules to do the following:
a. effectively and efficiently achieve the purposes of this article;
b. govern the methods, processes, and any other aspect of the research, creation, and testing of a treatment or therapeutic protocol for each disease for which a prize may be awarded.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to adopting the solemn covenant of the states to award prizes for curing diseases inter- state compact
Purpose
Adopts the solemn covenant of the states to award prizes for curing diseases through an interstate compact
Summary of specific provisions
Section 1 of the bill creates a new article 49-A of the public health law as it relates to an interstate compact to award prizes for curing diseases. The section titles the article Solemn Covenant of the States to Award Prizes for Curing Diseases. For the purpose of the bill, the terms compacting state, compact, non-compacting state, and state are defined. This section also establishes the rules and bylaws of the compact, and establishes the powers and duties of the commission. The powers and responsibilities of the commission includes reviewing treat- ments and therapeutic protocols for the cure of disease submitted to the commission, and to award prizes for submissions that meet the commis- sion's standards for a successful treatment. This section also provides for committees of the commission to be established once twenty-six states enact the compact and establishes a process by which a state may withdraw or be reinstated, as well as for expulsion of a compact state which has defaulted on its obligations or responsibilities under the compact.
Read the full memo (835 words)
Section 2 provides an effective date.
Justification
This bill, known as the Cure Bill, is an ingenious proposal which creates a new multi-state compact that would offer billions of dollars in cash prizes to those who develop actual cures for major diseases like cancer, Parkinson's disease, or Alzheimer's that are identified by the compact based on severity and cost.
Amazingly, despite huge advances in technology and spending on health care, the last major disease cured was Polio in 1955. Clearly, the current incentives are for companies to discover treatments, not cures, because treatments involve years of drugs and therapies and thus reap much larger financial benefits than cures. Even government and charity funding aimed at disease has not produced results. For example, despite the War on Cancer declared by the federal government in 1971, there have been no cures for cancer, which continues to be one of the leading caus- es of death. We need incentives beyond basic science that government funding provides to get human trials of that science. The Cure Bill aims to change the current state of affairs by enticing venture capitalists with huge prize money to seek cures. The funding would represent the savings member states realize in their public health care spending over a five-year period as a result of the cure.
At least six states must join the compact before it goes into effect, so the prize money would amount to many billions of dollars. However, member states are not on the hook for paying out all of that money before they realize the savings from the cure. Instead, the compact would borrow the money to pay the prize and take ownership of the patent for the cure which they could then mass produce and distribute afford- ably. These states will no longer be paying the costs of treatment for the disease or diseases through their public health programs, thus saving money. Noncompact states and even nations will pay a royalty for the cure to offset expenses, allowing those states that joined the compact to recoup their initial investment. It is truly a win-win, espe- cially for those states who join the compact and for all those individ- uals and their families suffering from illnesses for which a cure could be found.
If passed, this legislation would allowNew York to join other states at the ground level and enhance its status as an "owner" of cures developed as a result of the incentives offered by the compact. In 2019, Ohio became the first state to adopt the compact legislation. Since then, several other states have introduced compact legislation and begun to make progress toward adoption. New York State should immediately adopt this legislation to join the compact.
For far too long, New Yorkers and their families have suffered from debilitating, often life-threatening illnesses. The Cure Bill provides an opportunity for New York State to join fellow states and be an inno- vator by changing the current paradigm of healthcare research and incen- tivize the development and FDA approval of cures rather than treatments. There is nothing to lose. If no cure is found, states pay nothing. At worst, we see huge economic activity as the potential prize encourages investments in research toward cures. At best, we will finally discover cures that will benefit all of humanity.
Legislative history
2019-2020: S7770/A10429 Gottfried
2021-2022: S2123/A220 Gottfried
Fiscal implications
Potential savings as New York joins other states in encouraging cures which lower health care spending on treatments such as maintenance medi- cations and ongoing care.
Effective date
Immediately, provided the compact becomes effective and binding upon enactment of the compact legislation by six states.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.